HealthQuill Gene Editing
Sonia Vallabh, a graduate of Harvard Law School and her husband Ā Eric Minikel, who holds a planning degree from MIT, re-engineered their careers to do research into prion disease when she was diagnosed with the disorder. Now their research may lead to a treatment if not a cure in the not-too-distant future, according to a statement from Harvard.
Uncategorized

Patient-scientist behind new gene-editing tool for prion disease

HQ Team April 10, 2025: Ā Sonia Vallabh, a graduate of Harvard Law School and her husband Ā Eric Minikel, who holds a planning degree.

Read More
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified pigs to treat kidney disease.
Drugs Health Medical

US regulator approves pig organ transplant trial to treat kidney diseaseĀ 

United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.

Read More
Global researchers, led by Australiaā€™s Macquarie University, in a bid to re-engineer life in a laboratory, have completed the worldā€™s first synthetic yeast genome following more than a decade of work.
Drugs Health Medical

Global researchers complete worldā€™s first synthetic yeast genome project

Global researchers, led by Australiaā€™s Macquarie University, in a bid to re-engineer life in a laboratory, have completed the worldā€™s first synthetic yeast.

Read More
A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial of a therapy to treat chronic hepatitis B.
Drugs Health Pharma

Moldova green lights Precision BioSciences human trial for HBV

A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial.

Read More
Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.
Drugs Health Pharma

Roche to pay $42 million to Ascidian to make RNA exon editing drugs

Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.

Read More
The USFDA has approved two treatments for sickle cell disease, one of them the first in the US based on gene-editing technology.
Drugs Health Pharma

US drug regulator approves two treatments for sickle cell diseaseĀ 

HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US.

Read More
The University of Cambridge announced a partnership withĀ AstraZenecaĀ and theĀ Medical Research Council to set up a functional genomics laboratory at theĀ Milner Therapeutics Institute
Drugs Health Pharma

Cambridge Univ, AstraZeneca, MRC to set up genomics laboratory

HQ Team November 29, 2023: The University of Cambridge announced a partnership withĀ AstraZenecaĀ and theĀ Medical Research Council to set up a functional genomics laboratory.

Read More
AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in oncology, immunology and rare diseases.
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes ā€”an innovation which in future can fight cancer and diabetes.
Drugs Health Pharma

Biomedical engineers create ML model to turn genes on and off

HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes ā€”an innovation which.

Read More
US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria.
Drugs Health Pharma

Gene editing kills female mosquitoes that spread malaria

HQ Team July 10, 2023: US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria..

Read More